Summary.-The morphology of 20 mammary adenocarcinomas induced by 7,12-dimethylbenz(a)anthracene (DMBA) in Sprague-Dawley rats was compared with their growth characteristics and oestrogen-binding capacity following ovariectomy. The capacity to bind (3H)oestradiol-17B did not appear to be related to the growth characteristics, time of appearance after DMBA administration, or time between ovariectomy and assay for specific oestrogen-binding proteins. Furthermore, different tumours appeared to have oestrogen-binding capacities unrelated to the percentage of neoplastic cells within the tumour, amount of inflammation, mast cell infiltration, or the presence of fluid-filled cysts. The only morphological features which appeared to be correlated with oestrogen-binding capacity were the number of mitoses and the lipid content of the tumour; that is, the oestrogenbinding capacity tended to be lower in tumours with moderate or large numbers of mitoses and in tumours with much lipid in the epithelial cells.
MAMMARY tumours induced in rats by 7,1 2-dimethylbenz(a)anthracene (DMBA) have been the focus of extensive investigation because of some similarities between these rodent tumours and human breast cancer (e.g. histological heterogeneity, existence of both ovary-dependent and ovary-independent tumours, presence of specific oestrogen-binding proteins). A number of attempts to correlate the morphology of DMBA-induced tumours with certain parameters of tumour growth and biochemistry have met with variable success (Archer and Orlando, 1968; Daniel and Pritchard, 1967; DeSombre, Anderson and Kang, 1975; Hilf et al., 1970; Stevens, Stevens and Currie, 1965; Young, Cowan and Sutherland, 1963) . Oestrogen-binding proteins have been demonstrated and characterized in the normal mammary gland (Beers and Wittliff, 1973; Wittliff et al., 1972) and in ovary-dependent DMBA-induced mammary tumours of the rat (Boylan and Wittliff, 1975; DeSombre et al., 1976; Kyser, 1970; McGuire and Julian, 1971 ). Earlier we reported that many mammary tumours whose growth was ovary-independent contained specific oestrogen-binding proteins (Boylan and Wittliff, 1975) but no relationship between this parameter and tumour morphology or growth was presented. It is the intent of this paper to demonstrate and correlate some of the variable biological and biochemical parameters which exist among these chemically induced tumours. In demonstrating the diversity found among DMBA-induced tumours with respect to a number of parameters, we want to promote awareness of the hazards involved in the common practice of pooling tumours for biochemical assays.
MATERIALS AND METHODS
Tumours were induced in female SpragueDawley rats (Charles River Laboratories, Wilmington, Mass.) by gastric intubation of 5 mg DMBA (Sigma Chemical Co., St. Louis, Mo.) dissolved in 1 ml sesame-seed oil administered weekly for 5 weeks (total dose: 25 mg) beginningf when the animal was 49 days old. Four weeks after the final intubation, weekly palpations were begun on each rat; the time of appearance, position, and average diameter (measured with calipers through the skin) of all tumours were recorded. To eliminate fluctuating oestrogen levels, which interfere with determination of the oestrogen-binding capacity (OBC), bilateral ovariectomy was performed under ether anaesthesia at least 3 days before sacrifice and assay.
The animals were killed by cervical dislocation after light ether anaesthesia; tumours were excised and immersed immediately in ice-cold Tris-EDTA buffer (10 mM Tris HC1/1 5 mm EDTA, pH 7.4). The weight of the entire tumour was recorded before a representative section of the tumour was cut and fixed in 10% neutral buffered formalin for pathological examination. When the tumour appeared grossly heterogeneous, more than one area was sampled and fixed. Fixed tissues were embedded in paraffin, sectioned at 6 ,tm and stained with haematoxylin and eosin.
The tumours were evaluated morphologically, using the criteria for rat tumours presented by Young and Hallowes (1973) . The percentage of neoplastic tissue was estimated from areas of the tumour sections, after excluding the connective tissue capsule and large foci of necrosis, since these elements were eliminated before assay of the oestrogenbinding capacity.
The oestrogen-binding capacity was determined on small fragments of tumour from which the connective tissue capsule and necrotic tissue had been removed. Whenever possible, these fragments were taken from tissue adjacent to the portion fixed for pathological examination. However, when the tumours were small or predominantly necrotic, all tissues which appeared viable were pooled for analysis. The assay was performed after administration of [2,4,6,7-3H] oestradiol-17B (105 Ci/mmol; New England Nuclear Corp., Boston, Mass.) in vivo and/or in vitro, by sucrose density centrifugation as described earlier (Boylan and Wittliff, 1975) . S.c. injections of 0-2 jug (3H)-oestradiol-17B were made in the midventral area 30 min before killing. Since this dose of hormone did not saturate the available cytoplasmic binding sites, cytosols prepared from these tumours were incubated with (3H)-oestradiol-17B at a final concentration of 3-5 nm before centrifugation. Total binding capacity was expressed as the sum of fmol (3H)-oestradiol-17B bound per mg cytosol protein by cytosol saturated in vitro plus that in the nuclear extract. For assay in vitro, ligand was added to cytosol prepared from tumours not exposed to (3H)-oestradiol-17B in vivo.
RESULTS

Tumour incidence and di8tribution
Of 52 animals treated with DMBA, 46 (88%) developed at least one tumour; multiple tumours were very common. Although adenocarcinomas and fibroadenomas were most common, tumours of several other origins were observed. The distribution of 80 tumours in 27 animals was examined: (1) tumours were equally distributed on the left and right sides; and (2) evenly distributed among three general body regions: .head and neck, 31%; axilla, 33%; inguinal and anal, 35 %.
Mammary adenocarcinomas
The Table includes data from 20 adenocarcinomas arising in 13 rats all of which had ovariectomy at least 3 days before being killed. The total oestrogen- Eleven of the 20 tumours possessed moderate to marked stromal inflammation (Fig. 2) . The OBC of these 11 tumours varied between 3 and 74 fmol/mg cytosol protein and there appeared to be no correlation. The tumours that showed only regression had more inflammation (7/9) than those with static or steady growth, or regression followed by regrowth (4/10). There also appeared to be a correlation between the presence of moderate or marked inflammation and the time following ovariectomy when (Fig. 3) . the interpretation was made (date of killing). Of the 11 tumours with moderate to marked inflammation in the stroma, the average time between ovariectomy and killing was 22-9 days, whereas for the 9 tumours with little or no stromal inflammation, the average length of time was 62-4 days. There appeared to be little variation in the amount of inflammation seen in the different tumours from any one animal: e.g., 2/3 tumours from Animal 11, and 3/3 tumours from Animal 30 had marked inflammation, while both the tumours from Animals 10 and 42 had little or no inflammation.
Eight of the adenocarcinomas had many mast cells in the stroma, sometimes accompanying the inflammation described above. Except for one tumour whose FIG. 3.-Lipid-containing adenocarcinoma size remained unchanged, all these tujuxtaposed to fibroadenoma from rat in which tumour was regrowing after postmours were regressing or had regressed ovariectomy regression. H. and E. x 100.
spindle-shaped carcinoma cells. One of the hard nodules (IOA-i) was diagnosed as an extra-osseous osteosarcoma (Fig. 4) .
Three other adenocarcinomas in this study had areas of squamous metaplasia. Tumour 42B, located in the inguinal area, appeared uniform on gross examination, but was found to consist of both adenocarcinoma and fibroadenoma with intermingled borders (Fig. 3) . At the time of killing, this tumour had entered a new phase of growth following initial regression after ovariectomy. The OBC of this composite tumour was 4 fmol/mg cytosol protein.
Tumour 44A was diagnosed as a sebaceous basal-cell carcinoma and was located in the right inguinal region. The growth of this tumour was ovary-independent and it had an OBC of 9 fmol/mg cytosol protein. of the 20 tumours. No correlation could be found with the OBC (range 3 to 67 fmol/mg cytosol protein) interval between ovariectomy and killing (range 6 to 82 days) or growth characteristics (3 remained static or grew, 4 regressed only, and 2 regressed and regrew: one was found at killing). included in the study (52B) which regrew after regression, had areas of sebaceous differentiation and had an OBC of 5 fmol/mg cytosol protein.
Three tumours located on the dorsolateral surface of the head near the ear were diagnosed as highly keratinizing squamous carcinomas with areas of sebaceous differentiation (Zymbal gland tumours) (Fig. 5) . All lacked demonstrable EBC both in vivo and in vitro: their growth was totally ovary-independent.
DISCUSSION
The oestrogen-binding capacity and growth characteristics of a number of DMBA-induced mammary adenocarcinomas in ovariectomized rats were compared with the morphology of these neoplasms. OBC failed to correlate with most of the parameters evaluated, namely, time of appearance of the tumours after DMBA administration, the interval between ovariectomy and analysis, the growth characteristics of the tumours after ovariectomy, or the amount of viable neoplastic tissue, stromal inflammation, or number of mast cells in the tumours. The OBC of tumours with more mitoses was generally lower than that found in tumours with few mitoses, probably due to the decreased differentiation in the 9 rapidly proliferating tumours. However, 4/5 tumours with much lipid had an OBC <10 fmol/mg cytosol protein.
While the presence of concentrations of lipid usually reflects a considerable degree of differentiated function, this aspect of cell activity does not appear to be correlated with high levels of oestrogenbinding proteins. During a study of tumour regression, Gullino et al. (1972) found that DMBA-induced tumours accumulated triglycerides soon after ovariectomy. However, this does not account for the high lipid content in the 5 tumours discussed here, since one showed steady growth for 40 days after ovariectomy, and another tumour had regressed, and then entered a new phase of growth. (Boylan and Wittliff, 1973; Wittliff et al., 1972) .
The lack of correlation between OBC and the interval between ovariectomy and analysis would indicate that the ovaries alone are not necessary to maintain a significant population of oestrogen-binding proteins in these tumours. Takizawa et al. (1974) reported that most DMBA-induced tumours disappeared almost completely by 3 weeks after ovariectomy, whereas Dao (1964) reported that many tumours that initially regress following endocrine organ ablation begin to regrow after 2 months, but not to the extent they did before ablation. Five of the 20 tumours in this investigation showed some regrowth after regression, if they were allowed to remain in the host beyond 60 days after ovariectomy. The fibroadenoma found in one of these 5 regrowing tumours, and the sebaceous differentiation found in another, may indicate that the regrowth resulted from an entirely different tumour type from the original adenocarcinoma that regressed after ovariectomy.
Tumours other than adenocarcinomas have been described previously in rats administered DMBA (Dao, 1964; Huggins, Grand and Brillantes, 1961; Middleton, 1965) . However, to our knowledge, extraosseous osteosarcomas have not been reported previously arising in rats given DMBA at any age, even though sarcomalike transformation has been reported in poorly differentiated DMBA-induced adenocarcinomas (Archer and Orlando, 1968) . 
